Resmed Inc header image

Resmed Inc

RMD

Equity

ISIN null / Valor 321632

New York Stock Exchange, Inc (2026-08-06)
USD 223.24-0.35%

Resmed Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

ResMed Inc. is a global leader in the development and provision of innovative healthcare solutions, particularly focusing on the management and treatment of chronic diseases such as sleep apnea, COPD (Chronic Obstructive Pulmonary Disease), and other related conditions. The company distinguishes itself through its integration of digital health technologies and cloud-connected medical devices, which are designed to transform patient care by keeping individuals out of hospitals and enabling them to lead healthier lives. ResMed's offerings extend beyond individual patient care to include comprehensive software platforms aimed at supporting healthcare professionals and caregivers. These platforms facilitate the delivery of effective care in home or chosen care settings, thereby enhancing the quality of life for patients, reducing the burden of chronic diseases, and contributing to the reduction of healthcare costs. Operating in more than 140 countries, ResMed's approach to healthcare innovation emphasizes the importance of accessibility and efficiency in managing chronic health conditions on a global scale.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-20.4%1Y
24.5%3Y
-18.7%5Y

Performance

27.3%1Y
32.0%3Y
31.8%5Y

Volatility

Market cap

32382 M

Market cap (USD)

Daily traded volume (Shares)

1,786,086

Daily traded volume (Shares)

1 day high/low

232.18 / 228.6

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Insmed Inc
Insmed Inc Insmed Inc Valor: 12614415
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
33.86%USD 132.55
MEDICLIN AG
MEDICLIN AG MEDICLIN AG Valor: 1158721
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.31%EUR 4.22
Ste Virbac SA
Ste Virbac SA Ste Virbac SA Valor: 524407
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.48%EUR 343.50
Omnicell Inc
Omnicell Inc Omnicell Inc Valor: 1275961
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.72%USD 36.16
Schrodinger Inc
Schrodinger Inc Schrodinger Inc Valor: 51947209
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
8.60%USD 17.81
Novo Nordisk A/S
Novo Nordisk A/S Novo Nordisk A/S Valor: 129508879
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.24%DKK 293.60
Tilray Brands Inc
Tilray Brands Inc Tilray Brands Inc Valor: 42386407
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.34%USD 4.44
RadNet Inc
RadNet Inc RadNet Inc Valor: 2812237
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.64%USD 68.16
Hikma Pharmaceuticals PLC
Hikma Pharmaceuticals PLC Hikma Pharmaceuticals PLC Valor: 2324471
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
8.15%GBP 16.99
Torrent Pharmaceuticals Ltd
Torrent Pharmaceuticals Ltd Torrent Pharmaceuticals Ltd Valor: 2431611
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.66%INR 4,965.00